Pfizer (PFE, $42.21) vaccine gets FDA optimism before emergency approval meeting
Pfizer and BioNTech's jointly developed coronavirus vaccine could be effective after just one dose, the U.S. Food & Drug Administration said Tuesday in its first report. The report comes ahead of its Thursday assessment of the Emergency Use Authorization (EUA) request filed by Pfizer last month.
According to the FDA, individuals infected with COVID 19 could benefit from the Pfizer vaccine. The FDA noted that the vaccine's efficacy after one dose, but before the second dose, was around 52%; its efficacy for trial participants over the age of 55 was 94% after both doses. .It has not noted any specific concerns from the late-stage trials.
Last month, Pfizer said that the vaccine, called BNT162b2, had a 95% efficacy rate across all age and race demographics. The pharmaceutical company said it would be ready to distribute the vaccine 'within hours' of approval by the FDA.
The Centers for Disease Control would take the final decision on allocation at the state and national level.
PFE in downward trend: 10-day moving average moved below 50-day moving average on September 03, 2024
The 10-day moving average for PFE crossed bearishly below the 50-day moving average on September 03, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Show more
Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).
Industry description
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
Market Cap
The average market capitalization across the Pharmaceuticals: Major Industry is 86.34B. The market cap for tickers in the group ranges from 72.83K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is CRXTQ at 72.83K.
High and low price notable news
The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 6%. JCRRF experienced the highest price growth at 9%, while MIRA experienced the biggest fall at -16%.
Volume
The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 28%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was -41%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
The latest insights from the AI trading robots, specifically those accessible through "Swing Trader, Popular Stocks: Short Bias Strategy (TA&FA)," have proven to be noteworthy. One standout performer in their portfolio is DLTR, which boasted a commendable +5.60% gain over the previous week. DLTR has been on an impressive uptrend, recording gains for three consecutive days as of December 04, 2023. In the realm of technical analysis, a three-day upward movement is often perceived as a bullish signal.
The Tickeron quant team is delighted to introduce our best robot of the week tailored for Trend Traders. Our sophisticated AI Robot, has been designed for manual trading enthusiasts who value independent signal selection.
In the dynamic world of stock trading, the utilization of AI trading robots has become increasingly prevalent. One such example is the "Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)," which showcased its prowess by yielding a remarkable +4.98% gain while trading ZIM over the previous week. As we delve into the intricacies of ZIM's recent performance, let's analyze the earnings results, market indicators, and industry trends that shape the narrative.
In the ever-evolving landscape of financial markets, artificial intelligence (AI) trading bots have emerged as powerful tools, providing investors with automated strategies to navigate the complexities of stock trading. In this analysis, we delve into the recent performance of AI trading robots, specifically those accessible through "Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)," which demonstrated a remarkable +4.67% gain while trading MRVL over the previous week.
The Tickeron quant team proudly presents our top-performing AI robot for swing traders. This robot stands out with its remarkable accuracy, empowering traders to capitalize on diverse market conditions and transaction types. Demonstrating its proficiency, it achieved profitability in short trades during last week's strong uptrend in the US stock markets.
The use of artificial intelligence (AI) in trading has become increasingly prevalent, with bots proving their mettle in the dynamic world of stocks. In this analysis, we delve into the recent performance of AI trading robots, specifically those accessible through "Swing Trader: High Volatility Stocks for Active Trading (TA&FA)." One noteworthy achievement is the impressive +4.65% gain generated by these bots while trading AMD over the course of the previous week.
One such example is the "Trend Trader: Popular Stocks (TA&FA)" platform, where AI trading robots demonstrated their prowess by generating a notable gain while actively trading Adobe Inc. (ADBE) over the previous week. In this article, we delve into a technical analysis of ADBE's recent performance, shedding light on key indicators and recent earnings results.
These sophisticated algorithms leverage data analytics and machine learning to execute trades with speed and precision, aiming to capitalize on market fluctuations and volatility. In a recent demonstration of their prowess, the Swing Trader: Top High-Volatility Stocks v.2 (TA) platform showcased remarkable performance, yielding a notable +4.50% gain while trading XLK over the previous week.
This is particularly evident in the recent performance of bots accessible via "Day Trader: High Volatility Stocks for Active Trading (TA&FA)." These bots, often likened to efficient bot factories, have demonstrated remarkable proficiency, yielding a notable +4.08% gain while actively trading LRCX over the past week.
One notable example comes from "Swing Trader: Stocks from Financial Sector (TA&FA)," where these AI trading robots have proven their mettle, securing a commendable +4,07% gain while trading WABC over the past week. This achievement underscores the potential of AI-driven strategies in navigating the complexities of the financial markets.
The 'metabolic' category within the biotechnology industry has been witnessing remarkable growth, particularly in companies focused on developing drugs for gastrointestinal and metabolism disorders.
The portable device sector, encompassing companies involved in the production and sale of portable devices, witnessed a notable performance surge of +8.63% over the past week. This surge was led by prominent players including Apple (AAPL), CEVA, and Generac Holdings (GNRC). Despite this recent uptick, however, the sector currently faces a negative outlook, as indicated by various technical indicators and market sentiment analyses.
The Pulp & Paper industry, encompassing companies involved in the production of pulp, paper, and specialty paper products, has witnessed an impressive average stock gain of 11.68% over the last week.
In the whirlwind of the current mergers and acquisitions frenzy, investors are reaping substantial rewards as stocks within the merger industry theme surged by an impressive 20.9% on average over the past month.
The Tickeron quant team proudly introduces our premier AI Robot, tailor-made for trend traders who prefer manual trading and selecting their own signals. This AI Robot stands out with its impressive track record of consistent trading predictions, empowering traders to align their decisions with personal preferences.
Tickeron is excited to highlight the exceptional performance of our top AI robot this week, given the recent downturn in major US stock indices. While the SP500, NASDAQ 100, and Dow Jones Industrial all experienced declines, our AI robot, thanks to its well-calibrated diversification across various industries, demonstrated remarkable resilience.
Tickeron's quant team diligently monitors developed trading algorithms daily to determine the most effective ones. Today, we are delighted to present three of the best robots tailored for swing traders, showcasing consistently positive results over several months, irrespective of market conditions. This week, they underscored their efficacy by yielding impressive gains across various stocks, even as major US stock indexes dipped.
Tickeron is excited to highlight the exceptional performance of our top AI robot this week. The US stock market has experienced a consistent upward trend for the past five months, heightening the anticipation of a forthcoming correction with each passing day.
Introducing our top-performing best AI Robot of the week, designed by Tickeron's expert quant team for trading small-cap stocks. This algorithm blends classical and proprietary technical indicators, honed through advanced machine learning, to empower users with effective portfolio diversification and maximum profitability in the dynamic market.